• Episode 33: A Between the Biotech Waves conversation with Eliot Forster, xCEO of F-star Therapeutics

  • Jul 19 2023
  • Duración: 1 h y 5 m
  • Podcast
Episode 33: A Between the Biotech Waves conversation with Eliot Forster, xCEO of F-star Therapeutics Por arte de portada

Episode 33: A Between the Biotech Waves conversation with Eliot Forster, xCEO of F-star Therapeutics

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Today I am talking to Eliot Forster xCEO of F-star Therapeutics.
    Eliot was at helm of the company as they reversed merged into Springbank Pharmaceuticals & through the recently announced acquisition by Sino Biopharma, a transaction that generated a lot of interest given the very public interactions with CFIUS.
    Prior to F-star, Eliot was CEO of Immunocore, Creabilis and Solace Pharmaceuticals following his multiple roles at Pfizer which included head of development and operations, European Union. He was the founding chair of Medcity and is an honorary visiting professor of molecular and clinical cancer medicine at the University of Liverpool, to name just a few roles he has had. Eliot is a member of the board of directors of Immatics and is chair of the boards of Ochre Biosciences and Avacta.
    Más Menos
Más Menos

Lo que los oyentes dicen sobre Episode 33: A Between the Biotech Waves conversation with Eliot Forster, xCEO of F-star Therapeutics

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles